News Releases

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting

March 27, 2023

Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank

March 13, 2023

Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders

March 2, 2023

Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology

February 27, 2023

Anixa Biosciences Announces Formation of Breast Cancer Clinical Advisory Board

February 21, 2023

Anixa Biosciences to Present at Biotech Showcase 2023

December 19, 2022

Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine

December 8, 2022

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium

November 8, 2022

Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy

October 31, 2022

Anixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic

October 26, 2022

Latest News & Events

Jun 3, 2025

Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview

Read More...

Jun 2, 2025

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine

Read More...

May 19, 2025

Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones

Read More...